The Retrovirus Conference was created to provide a forum for scientists and clinicians to present, discuss, and critique developments in the field of human retrovirology and related opportunistic complications.

The retroviral subjects which will be highlighted are: biology and virology, pathogenesis, host-virus interactions, pathology, immunology, epidemology, diagnostics, prevention, therapy, pharmaceology, and vaccines. In addition, new scientific studies concerning the pathogenisis, immunology, pathogen-host interactions, pathogen-HIV interactions, diagnosis, treatment, and prevention of HIV-associated opportunistic infections and malignancies will be included.

Below you can read some of Dr. Torres' and Dr. Pavia's answers to recent questions about the Fourth Retrovirus Conference asked by visitors to The Body.

Answers to Questions:

• undectable on crix for one year(March 19, 1997)
• Combining Crixivan with Saquinavir(March 17, 1997)
• Dangers of early PI treatment(March 17, 1997)
• gastrointestinal problems from ratonavir and saquinavir combo(March 17, 1997)
• Choosing a protease inhibitor(March 17, 1997)
• increasing liver enzymes under d4T and Ritonavir/Saquinavir(March 17, 1997)
• norvir/invirase/3tc/d4t combination therapy(March 17, 1997)
• How to avoid diarrheas by Saquinavir/Invirase?(March 17, 1997)
• additional effect of Nevirapine?(March 11,1997)
• detecting HIV before seroconversion(March 11,1997)
• When to initiate Anti-retroviral therapy(March 10,1997)
• mental anguish for being infected with needle of hiv patient(March 10,1997)
• Definition of provirus
• HIV PROTEASE INHIBITORS EFFECTS ON HEP C PROTEASEr
• Begining nelfinavir after indinavir
• ritonavir and saquinavir fatique?
• Mouth sores
• Status report on the integrase inihbitors
• My NEW CD4's. Are they functioning?
• Future protease inhibitors
• Are treatments effective on other subtypes?
• Interleukin II